In the BioHarmony Drug Report Database

"Preview" Icon

Nadolol

Corgard (nadolol) is a small molecule pharmaceutical. Nadolol was first approved as Corgard on 1982-01-01. It is used to treat angina pectoris, heart failure, hypertension, and myocardial infarction in the USA. The pharmaceutical is active against beta-1 adrenergic receptor and beta-2 adrenergic receptor. In addition, it is known to target beta-3 adrenergic receptor.

 

Trade Name

 

Corgard
 

Common Name

 

nadolol
 

ChEMBL ID

 

CHEMBL649
 

Indication

 

angina pectoris, heart failure, hypertension, myocardial infarction
 

Drug Class

 

Analgesics (mixed opiate receptor agonists/antagonists); beta-blockers (propranolol type)

Image (chem structure or protein)

Nadolol structure rendering